ProQR Therapeutics (PRQR) Treasury Shares (2016 - 2026)

ProQR Therapeutics (PRQR) has reported Treasury Shares for 11 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.

• Quarterly Treasury Shares fell 0.83% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 0.83% YoY) and the FY2025 annual result came in at $2.7 million, down 5.95% from the prior year.
• Treasury Shares steadied at $2.7 million in Q1 2026 per PRQR's latest filing, from $2.7 million in the prior quarter.
• Over the last five years, Treasury Shares for PRQR reached as high as $4.1 million in Q1 2022 and fell as low as $2.7 million in Q1 2026.
• A 5-year average of $3.3 million and a median of $2.9 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares retreated 22.38% — and 2026, when it decreased 0.83%.
• Year by year, Treasury Shares stood at $3.9 million in 2022, then declined by 15.63% to $3.3 million in 2023, then slipped by 13.66% to $2.8 million in 2024, then declined by 5.95% to $2.7 million in 2025, then fell by 0.06% to $2.7 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.7 million, $2.7 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.